Same Indication

Nivolumab vs Omeprazole

Nivolumab vs Omeprazole: Overview

This comparison examines the pharmacological differences between Nivolumab and Omeprazole.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Omeprazole: Proton pump inhibitor that irreversibly blocks H+/K+-ATPase.

Pharmacokinetics

Half-life: Nivolumab — 27 days; Omeprazole — 0.5-1 hour.

Chemical Properties

Molecular Formula: Omeprazole — C17H19N3O3S.

Molecular Weight: Omeprazole — 345.4170 g/mol.

Type: Nivolumab — Antibody; Omeprazole — Small molecule.